Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
07/2002
07/18/2002CA2433950A1 Therapeutic chromone compounds
07/18/2002CA2433742A1 Proteins and nucleic acids encoding same
07/18/2002CA2433653A1 Regulation of lipids and/or bone density and compositions therefor
07/18/2002CA2433449A1 Metabolic gene polynucleotides and polypeptides and uses thereof
07/18/2002CA2432350A1 Method for inhibiting the expression of a target gene
07/18/2002CA2432114A1 4-(hetero)aryl substituted indolinones
07/18/2002CA2430588A1 Modulation of pericyte proliferation using bpi protein products or bpi inhibitors
07/18/2002CA2428497A1 Targeted modification of intracellular compounds
07/18/2002CA2428075A1 Fumaric acid derivatives as nf-kappab inhibitors
07/17/2002EP1223170A1 Pyrimidine-5-carboxamide compounds, process for producing the same and use thereof
07/17/2002EP1222920A2 Mitochondria protecting agents for treating mitochondria associated diseases
07/17/2002EP1222854A1 Prevention and treatment of diseases associated with blood coagulation
07/17/2002EP1222683A1 Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease
07/17/2002EP1222463A2 Allosteric sites on muscarinic receptors
07/17/2002EP1222302A1 Process for producing, methods and compositions of cholesterol lowering agents from higher basidiomycetes mushrooms
07/17/2002EP1222286A2 Aortic carboxypeptidase-like protein and nucleic acids encoding same
07/17/2002EP1222279A2 Growth factor polypeptides and nucleic acids encoding same
07/17/2002EP1222276A2 Polynucleotides and polypeptides encoded thereby
07/17/2002EP1222273A2 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same
07/17/2002EP1222253A1 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies
07/17/2002EP1222226A1 Highly-neutralized ethylene copolymers and their use in golf balls
07/17/2002EP1222204A1 A DNA MOLECULE ENCODING A VARIANT $g(a) 2B?-ADRENOCEPTOR PROTEIN, AND USES THEREOF
07/17/2002EP1222201A2 Peptides which stimulate the immune response and tissue regeneration
07/17/2002EP1222195A1 Novel thiazolo(4,5-d)pyrimidine compounds
07/17/2002EP1222193A2 Imidazole derivatives as phosphodiesterase vii inhibitors
07/17/2002EP1222191A2 Benzodiazepin derivatives, the production and use thereof
07/17/2002EP1222188A1 Novel imidazopyridine carbonitrile compounds
07/17/2002EP1222187A2 Heterocyclic compounds useful as inhibitors of tyrosine kinases
07/17/2002EP1222183A1 Benzopyran derivatives
07/17/2002EP1222182A2 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans
07/17/2002EP1222180A2 Enantiomeric compounds for treatment of cardiac arrhythmias and methods of use
07/17/2002EP1222175A1 4,5-disubstituted-2-aminopyrimidines
07/17/2002EP1222171A1 Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
07/17/2002EP1222170A1 Novel nicotinonitrile compounds
07/17/2002EP1222169A1 Novel trisubstituted pyridine compounds
07/17/2002EP1222163A1 2'-substituted 1,1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as a medicament and pharmaceutical preparations containing said compounds
07/17/2002EP1222162A1 Novel ltb 4? antagonist, method for the production thereof and its use as a medicament
07/17/2002EP1221952A1 Use of central cannabinoid receptor antagonist for preparing medicines
07/17/2002EP1221941A1 Powder pharmaceutical formulations
07/17/2002EP1221939A1 Ortho ester lipids
07/17/2002EP1221868A1 Dietary supplement
07/17/2002EP1146891A4 Inhibiting development of microvessels within vascular walls
07/17/2002EP1083900B1 Use of of oxazolidinones for the preparation of a medicament for transdermal delivery
07/17/2002EP0888340B1 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists
07/17/2002EP0888298B1 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
07/17/2002EP0882044B1 1,4-dihydropyridine compounds as bradykinin antagonists
07/17/2002EP0830374B1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
07/17/2002EP0823254B1 Novel use of pyrazolopyridine compounds
07/17/2002EP0598061B1 Novel 4-oxocyclic ureas useful as antiarrhythmic and antifibrillatory agents
07/17/2002CN1359390A Factor VII a inhibitors
07/17/2002CN1359383A Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process
07/17/2002CN1359381A Thiazole-derivaties
07/17/2002CN1359378A 2-oxy-benzoxazine derivatives for the treatment of obesity
07/17/2002CN1359377A Dihydrobenzodiazepins and their use for treating dyslipidemia
07/17/2002CN1359376A Carboxylic acid derivatives compriosing aryl-substituted nitrogen heterocycles, their production and their use as endothel in receptor antagonists
07/17/2002CN1359373A 6[(aryl and heteroaryl)oxy] methyl] naphthalene-2-carboximidamide derivatives, preparation and therapeutic application thereof
07/17/2002CN1359295A Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug
07/17/2002CN1359294A Pharmaceutical composition in unit form containing acetylsalcylic acid and clopidogrel
07/17/2002CN1359290A Medicinal compositions for preventing or treating viral myocarditis
07/17/2002CN1358723A Novel bicyclic amino-pyrazino ketone compound, its preparation method and medicinal composition having same
07/17/2002CN1358543A Recombination plasmid and application in disease prevention and control
07/17/2002CN1358540A Strong osmotic medicine core of ointment
07/17/2002CN1358520A Capsule for pressure-increasing powder medicine
07/17/2002CN1358498A Hermorrhoid medicinal plaster
07/17/2002CN1087741C New indole and inidazole compounds, process for their preparation and pharmaceutical compositions containing them
07/17/2002CN1087737C Dihygropyridine derivatives as bradykinin ant agonists
07/17/2002CN1087725C Enhancement of the effect of drugs by deuteration
07/17/2002CA2367825A1 Antithrombin iii for disorders caused by angiogenesis
07/16/2002US6420624 Blood circulation-promoting powdery material, blood circulation-promoting attachment sheet and blood circulation-promoting attachment sheet set
07/16/2002US6420591 Carbamates and compositions thereof, and methods for their use for treating cancer, inflammation, or a viral infection
07/16/2002US6420568 Compounds for antifibrillatory and antiarrhythmic agents. the processes of this invention are useful for making
07/16/2002US6420567 Prodrugs
07/16/2002US6420561 Piperazinyl or piperidinyl acid derivatives for treatment of rheumatic diseases, arthritis due to gout and antiinflammatory agents
07/16/2002US6420414 Amino derivatives of EM-138 and methods of treating angiogenesis with same
07/16/2002US6420408 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases
07/16/2002US6420393 Nuclear factor .kappa.b-dependent disease selected from the group consisting of inflammatory diseases, immunological disorders, septic shock, transplant rejection, radiation damage, reperfusion injuries after ischemia, stroke or
07/16/2002US6420392 Paf receptor antagonists and/or by inhibiting the enzyme 5-lipoxygenase.
07/16/2002US6420386 Spinal traumatism, epilepsy, chronic neurodegenerative diseases such as alzheimer's disease, schizophrenia, lateral amyotrophic sclerosis or huntington's chorea.
07/16/2002US6420385 Substituted pyrimidinone and pyridone compounds and methods of use
07/16/2002US6420383 Calcium channel blockers, hypersensitivity, allergy, asthma, bronchospasm, dysmenorrhea, esophageal spasm, glaucoma, premature labor, urinary tract disorders, gastrointestinal motility disorders and cardiovascular disorders.
07/16/2002US6420382 Tyrosine kinase inhibitors
07/16/2002US6420373 9-N-Bicyclic nuceoside agents useful as selective inhibitors of proinflammatory cytokines
07/16/2002US6420368 Thienopyrimidines
07/16/2002US6420364 Treating autoimmune diseases,alzheimer's disease, atherosclerosis, osteoporosis,
07/16/2002US6420345 Methods and reagents for inhibiting angiogenesis
07/16/2002US6420342 Ribose, folic acid, orotic acid
07/16/2002US6420341 Treating vasoconstrictor and hypertension effects in warm-blooded animals
07/16/2002US6420335 Cancer therapy; angiostatin or endostatin to sensitize tumor endothelial cells to ionizing radiation
07/16/2002US6420155 Polypeptide for use in the treatment of cancer and atherosclerosis
07/16/2002US6420150 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
07/16/2002US6420124 KVLQT1—a long qt syndrome gene
07/16/2002US6420118 Monitoring activity of mutant tumor suppressor protein; obtain sample containing mutant peptide, incubate with wild type cell, monitor tumor suppression activity of cells
07/16/2002US6419954 Mixture containing gelled polymer
07/16/2002CA2286296C Inhibitors for urokinase receptor
07/16/2002CA2059704C [[2-(amino-3,4-dioxo-1-cyclobuten-1-yl)amino]alkyl]-acid derivatives
07/16/2002CA2052392C Extract from ginkgo biloba leaves, in particular for intravenous injection or infusion, a method of preparation of the extract and ampoule preparations containing the extract
07/16/2002CA1341377C Composition and method for acceleration of clot lysis
07/11/2002WO2002053775A2 Identification of genetic determinants of polymorphic cyp3a5 expression
07/11/2002WO2002053742A2 Proteins and nucleic acids encoding same
07/11/2002WO2002053717A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof